Edwards Lifesciences Shares Outstanding 2006-2018 | EW

Edwards Lifesciences shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Edwards Lifesciences shares outstanding for the quarter ending September 30, 2018 were 0.213B, a 1.39% decline year-over-year.
  • Edwards Lifesciences 2017 shares outstanding were 0.216B, a 0.87% decline from 2016.
  • Edwards Lifesciences 2016 shares outstanding were 0.218B, a 1.13% decline from 2015.
  • Edwards Lifesciences 2015 shares outstanding were 0.22B, a 1.52% increase from 2014.
Edwards Lifesciences Annual Shares Outstanding
(Millions of Shares)
2017 216
2016 218
2015 220
2014 217
2013 228
2012 237
2011 239
2010 238
2009 235
2008 238
2007 251
2006 256
2005 249
Edwards Lifesciences Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 213
Q2 2018 214
Q1 2018 215
Q4 2017 216
Q3 2017 216
Q2 2017 216
Q1 2017 216
Q4 2016 218
Q3 2016 218
Q2 2016 217
Q1 2016 218
Q4 2015 220
Q3 2015 220
Q2 2015 220
Q1 2015 221
Q4 2014 217
Q3 2014 217
Q2 2014 215
Q1 2014 217
Q4 2013 228
Q3 2013 226
Q2 2013 229
Q1 2013 233
Q4 2012 237
Q3 2012 238
Q2 2012 237
Q1 2012 236
Q4 2011 239
Q3 2011 238
Q2 2011 240
Q1 2011 241
Q4 2010 238
Q3 2010 238
Q2 2010 238
Q1 2010 238
Q4 2009 235
Q3 2009 235
Q2 2009 234
Q1 2009 234
Q4 2008 238
Q3 2008 236
Q2 2008 241
Q1 2008 234
Q4 2007 251
Q3 2007 250
Q2 2007 252
Q1 2007 254
Q4 2006 256
Q3 2006 254
Q2 2006 257
Q1 2006 258
Q4 2005 249
Q3 2005 239
Q2 2005 250
Q1 2005 260
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $33.475B $3.435B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.279B 21.97
Intuitive Surgical (ISRG) United States $56.165B 55.26
Fresenius Medical Care AG KGaA (FMS) Germany $20.859B 14.10
IDEXX Laboratories (IDXX) United States $16.408B 46.87
ABIOMED (ABMD) United States $14.241B 102.33
Hologic (HOLX) United States $12.130B 18.72
Teleflex (TFX) United States $11.377B 25.83
Varian Medical Systems (VAR) United States $10.852B 27.01
DexCom (DXCM) United States $10.720B 0.00
STERIS (STE) United Kingdom $9.561B 25.37
Masimo (MASI) United States $5.673B 36.78
LivaNova (LIVN) United Kingdom $4.598B 29.52
Globus Medical (GMED) United States $4.389B 27.51
Penumbra (PEN) United States $4.327B 261.25
Integra LifeSciences Holdings (IART) United States $4.122B 20.08
Wright Medical Group (WMGI) Netherlands $3.442B 0.00
Cantel Medical (CMD) United States $3.310B 32.65
Inogen (INGN) United States $2.792B 60.27
Integer Holdings (ITGR) United States $2.729B 22.84
Halyard Health (AVNS) United States $2.274B 20.49
Glaukos (GKOS) United States $2.255B 0.00
Tandem Diabetes Care (TNDM) United States $2.028B 0.00
OPKO Health (OPK) United States $1.842B 0.00
Mazor Robotics (MZOR) Israel $1.535B 0.00
Nevro (NVRO) United States $1.192B 0.00
Luminex (LMNX) United States $1.138B 41.16
Pacific Biosciences Of California (PACB) United States $1.112B 0.00
AxoGen (AXGN) United States $1.096B 0.00
Natus Medical (BABY) United States $1.082B 22.71
CryoLife (CRY) United States $1.057B 92.19
Orthofix (OFIX) United States $1.039B 30.00
Intersect ENT (XENT) United States $0.935B 0.00
Tactile Systems Technology (TCMD) United States $0.932B 148.44
Mesa Laboratories (MLAB) United States $0.799B 47.23
AngioDynamics (ANGO) United States $0.779B 27.26
Accelerate Diagnostics (AXDX) United States $0.699B 0.00
ViewRay (VRAY) United States $0.602B 0.00
Veracyte (VCYT) United States $0.495B 0.00
SI-BONE INC (SIBN) United States $0.491B 0.00
Sientra (SIEN) United States $0.441B 0.00
OrthoPediatrics (KIDS) United States $0.422B 0.00
Quotient (QTNT) Switzerland $0.391B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.367B 0.00
Neuronetics (STIM) United States $0.353B 0.00
Accuray (ARAY) United States $0.328B 0.00
SeaSpine Holdings (SPNE) United States $0.307B 0.00
Fluidigm (FLDM) United States $0.306B 0.00
IRadimed (IRMD) United States $0.295B 77.20
Nuvectra (NVTR) United States $0.293B 0.00
RTI Surgical (RTIX) United States $0.263B 41.50
GenMark Diagnostics (GNMK) United States $0.256B 0.00
Helius Medical Technologies (HSDT) United States $0.253B 0.00
Pulse Biosciences (PLSE) United States $0.203B 0.00
T2 Biosystems (TTOO) United States $0.173B 0.00
Alphatec Holdings (ATEC) United States $0.108B 0.00
Ekso Bionics Holdings (EKSO) United States $0.103B 0.00
Ra Medical Systems (RMED) United States $0.099B 0.00
Sensus Healthcare (SRTS) United States $0.092B 0.00
Apollo Endosurgery (APEN) United States $0.088B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.085B 0.00
Second Sight Medical Products (EYES) United States $0.067B 0.00
Biosig Technologies (BSGM) United States $0.065B 0.00
EDAP TMS (EDAP) France $0.064B 0.00
Viveve Medical (VIVE) United States $0.042B 0.00
OBALON THERPTCS (OBLN) United States $0.040B 0.00
Restoration Robotics (HAIR) United States $0.038B 0.00
Vermillion (VRML) United States $0.035B 0.00
ConforMIS (CFMS) United States $0.033B 0.00
PAVmed (PAVM) United States $0.028B 0.00
Lianluo Smart (LLIT) China $0.027B 0.00
Dynatronics (DYNT) United States $0.021B 0.00
Titan Medical (TMDI) Canada $0.021B 0.00
DarioHealth (DRIO) Israel $0.019B 0.00
Neovasc (NVCN) Canada $0.015B 0.00
Bioanalytical Systems (BASI) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.014B 0.00
ENDRA Life Sciences (NDRA) United States $0.011B 0.00
Presbia (LENS) Ireland $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Avinger (AVGR) United States $0.008B 0.00
ReWalk Robotics (RWLK) Israel $0.008B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.006B 0.00
Microbot Medical (MBOT) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Amedica (SINT) United States $0.005B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00